A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
This accidental discovery, made by medical biochemist Henry Pownall, Ph.D., and his team at the Houston Methodist Research Institute, reveals a new pathway in the cholesterol-elimination chain that will be key to developing new drugs to lower cholesterol. Their findings are described in an article titled “ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate,” appearing online Oct. 26 and in print Nov. 21 in the American Heart Association’s Arteriosclerosis, Thrombosis, and Vascular Biology journal.
VIDEO: Dr. Pownall explains the research https://vimeo.com/239663429
Pownall, who is the corresponding author, said the initial purpose of their study was to prove the current model of cholesterol transport through the body was correct. It turns out, however, that the model was not quite right.
“The model people have been using for 40 years presumed that cholesterol was transported from the arteries with other lipids and proteins and entered a particle that stayed in the blood for several days before being cleared by the liver for disposal,” Pownall said. “What we discovered in the process was something different. We discovered the cholesterol skips all these steps and goes directly from this early particle to the liver in two minutes. This is a thousand times faster than what was formerly suspected.”
While most studies look at HDL cholesterol in its mature form found in blood, Pownall and his colleagues studied cholesterol in nascent HDL, an early form of HDL produced by cells. Cholesterol in the nascent HDL goes directly to the liver, largely skipping conversion to the mature form of HDL
Pownall stresses that it’s not that current practices of treating “bad” LDL cholesterol are incorrect, but instead that physicians and researchers need to better understand how the “good” HDL cholesterol contributes to cardiovascular disease and how to raise it in a way that protects the heart, because some patients with very high HDL numbers, which were always thought to be beneficial, are actually at risk.
“LDL cholesterol, the so-called ‘bad cholesterol’ is well controlled with the current statin therapies. The track record for these cholesterol-lowering drugs is indisputable, and they will continue to work,” Pownall said. “HDL, or the ‘good cholesterol,’ however, is a much trickier system. Not everything that raises it protects the heart and not everything that lowers it is bad for you. We will need to redesign new drugs to lower plasma cholesterol in a way that takes into account this new mechanism. We will look for interventions – maybe dietary, maybe pharmacological – that raise HDL cholesterol in a way that helps protect the arteries and prevent cardiovascular disease.”
Researchers collaborating with Pownall on this paper were Bingqing Xu, Baiba K. Gillard, Antonio M. Gotto Jr., and Corina Rosales, and the work was supported by a High-density Lipoprotein (HDL) Biogenesis and Speciation grant from the National Institutes of Health’s National Lung, Heart and Blood Institute (R01HL129767), Deutsche Forschungsgemeinschaft (Exc114-2) and Fondren Foundation.
For more information: ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate. Arteriosclerosis, Thrombosis, and Vascular Biology DOI: https://doi.org/10.1161/ATVBAHA.117.310290 (Oct. 26, 2017) B. Xu, B.K. Gillard, A.M. Gotto Jr., C. Rosales, H.J. Pownall.
RT @RiceVolleyball: PREVIEW: Owls set to close out homestand Sunday (1 p.m.) vs. Louisiana Tech.📰 https://t.co/w1R3VcrlOQ #GoOwls👐
TAMU Health Sciences@TAMHSC
RT @WebMD: For the first time, "gaming disorder" has officially been recognized by the World Health Organization (@WHO) as a #mentalhealth condition. https://t.co/a4C24i5Hkl https://t.co/j9KroEIFuY
CHI St. Luke's Health@CHI_StLukes
We're excited to partner with @HoustonBCycle to open a station in the @TXMedCenter! Hope to see you at the ribbon cutting! RSVP here: https://t.co/fZUzvbOWun https://t.co/OfYH8t81Vl
More than 72 banners hung downtown Rapid City, SD to honor area Veterans https://t.co/4M9I3AChAf via @kotatweets
Bring your health questions and walking shoes and join us tomorrow from 8 to 9 a.m. for our next Walk With A Doc event at @HermannPark! MORE INFO: https://t.co/YnsDzAjp1K #ManyFacesOfUTHealth #exercise #healthtips https://t.co/DxQJ3nyDSu
RT @bcmgcprogram: October is Rett Syndrome Awareness Month. Learn more from @Rettsyndrome and read more about the @TexasChildrens Rett Cent…
We are so thankful for the generous support of The Moody Endowment that allows us to have this fantastic new mobile mammography unit to help serve women across the area.
University of Houston@UHouston
👀H-TOWN REPRESENT https://t.co/OeoCdsaPoQ
RT @CDCgov: You can’t see them, but germs are everywhere! Protect yourself and your family from getting sick by washing your hands the righ…
Formerly homeless soldier helping other Veterans in San Francisco https://t.co/lGOxNbns1w via @kron4news
RT @BCMHouston_News: Arianna Huffington shared her wisdom on aging, thriving and wellness at the @bcmhouston @HCOA_BCM 30th Anniversary cel…
@jmw3tx You're in our thoughts, Jeannie. Thanks for sharing your experience.
RT @TXMedCenter: To share the #beauty of his #cleftlipandpalate patients’ #smiles with the world, #pediatric plastic surgeon, Matthew Greiv…
@AdamGenez We appreciate your feedback and have shared your concern to the appropriate contact person.
RT @BCMHouston_News: Researchers at @bcmhouston and @TexasChildrens uncover a connection between proteins mTORC1 and Src, which are known t…